Skip to content
ARMK

Aramark

Aramark Q3 FY2025 earnings call

August 5, 2025 · fiscal period ended 2025-06

EPS · actual vs est

/

Revenue · actual vs est

/
Ask about this call

Summary

Generated 2025-08-05

Management highlights

Key Points - Record revenue and profitability in Q3 with adjusted EPS growth near 30%. - Significant new client wins, including a large Sports & Entertainment account. - Client retention rate exceeded 97% in both FSS U.S. and International. - FSS U.S. organic revenue growth driven by base business, new client wins, and vertical opportunities. - International organic revenue growth led by multiple geographies, with strong new business wins. - Global supply chain leveraging AI for efficiency in sourcing and contract management. - Disciplined capital allocation with focus on debt repayment, dividends, and share repurchases.

View in transcript ↓

Segment performance

Aramark's revenue in the third quarter grew to $4.6 billion, a 6% increase with slight FX favorability. Organic revenue increased over 5%. FSS U.S. organic revenue was $3.2 billion, a ~3% increase in the third quarter, led by strong performance in Workplace Experience, Refreshments, Education, and Sports & Entertainment. International organic revenue was $1.4 billion, a 10% increase in the third quarter, with every geography experiencing growth led by the U.K., Chile, Canada, and Spain. Global supply chain is effectively managing the tariff environment, with focus on GPO expansion and AI-driven technology to enhance efficiency.

View in transcript ↓

Guidance

Forward-looking Statements - Reaffirmed FY25 guidance with confidence in hitting projections. - Strong Q4 start with high retention rates and new business impact. - Expectation of continued revenue growth and profitability driven by base business expansion and net new business. - Confidence in navigating broader marketplace with diversified portfolio and AI capabilities.

View in transcript ↓

Risks

Risks Identified - Tariff volatility could impact business. - Medical expenses and prescription drug costs (e.g., GLP-1 drugs) could affect margins. - Potential labor disruptions related to technology implementation in some business lines. - Impact of new account openings on short-term margins due to mobilization costs.

View in transcript ↓

Q&A highlights

Q: Can you give perspective on Q4 revenue acceleration and sequencing of big wins?

A: John Zillmer and Jim Tarangelo mentioned strong Q4 start, high retention, new contract wins coming online, and normal pricing activity in education and K-12 sectors contributing.

Q: What about the A's contracts and potential equity investment?

A: James Tarangelo and John Zillmer discussed the small equity investment in the A's, not tied to contract duration, and it's not part of current projections.

Q: How is the education segment selling season and retention?

A: John Zillmer stated education selling season still ongoing with strong net new business and very high retention rates, driven by performance and relationships, not pricing or investment.

Q: What gives confidence in Q4 revenue guide?

A: James Tarangelo and John Zillmer mentioned high retention rates, strong start after July, new large account rollouts, and pricing impacts in education and Corrections sectors contributing to the guide.

Q: About profitability improvements in Education and B&I in U.S. and per cap spending in Sports & Leisure?

A: John Zillmer and James Tarangelo discussed per cap spending in MLB being strong, and Education and B&I margins approaching pre-lockdown levels with revenue significantly above 2019.

View in transcript ↓

Key numbers

Reported versus consensus

Earnings calendar feed

MetricReportedConsensusDeltaPrior year
EPS
Revenue

Transcript

August 5, 2025

Full transcript unavailable for redistribution

The structured summary above covers the available call sections. Full transcript text is not included on this page.

Continue exploring

Prior quarters

This page presents the stored structured earnings-call summary and deterministic earnings calendar values. How this is generated. For informational purposes only; not investment advice.